Effectiveness and safety of anlotinib with or without S-1 in the treatment of patients with advanced hepatocellular carcinoma in a Chinese population: a prospective, phase 2 study

URN:NBN:SI:doc-JIL9J6FW2023Kang, Mafeidocuments/doc/J/URN_NBN_SI_doc-JIL9J6FW_001.pdfdocuments/doc/J/URN_NBN_SI_doc-JIL9J6FW_001.txt357articlestr. 405-410, XIV10.2478/raon-2023-00361318-2099228193539URN:NBN:SI:doc-JIL9J6FWengCroatian Medical Association - Croatian Society of RadiologySlovenian Medical Society - Section of RadiologyRadiology and oncology (Ljubljana)BYmonoterapijanapredovali hepatocelularni karcinomneželeni učinkionkologijaEffectiveness and safety of anlotinib with or without S-1 in the treatment of patients with advanced hepatocellular carcinoma in a Chinese population: a prospective, phase 2 study